New Neurological Findings and Documentation System Developed at Göttingen University

MEDNOVO Medical Software Solutions GmbHAn innovative neurological findings and documentation system named "NEMESYS" has been developed in the Department of Clinical Neurophysiology at Göttingen University School of Medicine. As regards content NEMESYS was developed in the Department of Clinical Neurophysiology at the University Hospital Göttingen (UKG) by Professor (Prof. Dr.) W. Paulus, Director of the Department of Clinical Neurophysiology, and private lecturer (Priv. Doz. Dr. med.) F. Tergau, St. Bernward Hospital in Hildesheim, formerly Department of Clinical Neurophysiology of the UKG. Technically NEMESYS was developed by Dipl. Phys. J. Lessing (Faculty of Physics).

From the left: Dipl.-Ing. Markus Mladek (MBM), Michael Heinlein (Managing Director  MEDNOVO Medical Software Solutions GmbH), Dr. Hans-Joachim Conrad (Executive Board of Management and Administration of the Göttingen University School of Medicine), Prof. Dr. Walter Paulus (Director of the Department of Clinical Neurophysiology)
From the left (Photo: umg): Dipl.-Ing. Markus Mladek (MBM), Michael Heinlein (Managing Director MEDNOVO Medical Software Solutions GmbH), Dr. Hans-Joachim Conrad (Executive Board of Management and Administration of the Göttingen University School of Medicine), Prof. Dr. Walter Paulus (Director of the Department of Clinical Neurophysiology).

MBM ScienceBridge GmbH, the technology transfer organization of Göttingen University, has been able to win the company MEDNOVO Medical software Solutions GmbH from Berlin as a licence partner for NEMESYS. "This partnership of science and economy again is a good example how our inhouse innovations are financially sensibly transformed into a marketable product for the single scientist and for Göttingen University", says Dr. Hans-Joachim Conrad, Executive Board of Management and Administration of the Göttingen University School of Medicine. The two partners have now signed a cooperation agreement.

NEMESYS is an absolute novelty in its function and its applicability in neurology: NEMESYS runs as a client-server-application on a database. By digital connection to neurological derivation devices (e.g. EEG, EMG), it is possible for the first time to work on different networked workplaces. Moreover, NEMESYS simplifies and standardizes the findings documentation in the area of Clinical Neurophysiology. The new system provides finding modules for the essential neurodiagnostical examination proceedings like EEG, EMG, EP, transcranial magnet stimulation, doppler-/ duplex sonography and EEG monitoring.

NEMESYS was certified by the German Society for Clinical Neurophysiology and Functional Imaging (DGKN). The extent of documentation as well as structure and classification of the findings modules were developed in arrangement with the DGKN and geared at international documentation standards.

Professor Walter Paulus, Director of the Department of Clinical Neurophysiology at the UKG: "We are pleased to have found an innovative partner like the company MEDNOVO, who will not only market but also enhance NEMESYS."

MEDNOVO offers the system NEMESYS as an additional module for its product family MediColor, an imaging and findings documentation system in functional diagnostics. Michael Heinlein, Managing Director of MEDNOVO Medical Software Solutions GmbH: "With the acquisition of NEMESYS we can complement the content of our system MediColor very well. In the near future, we will offer MediColor-Nemesys not only in Germany but also internationally."

NEMESYS is already in use at the University Hospital of the Georg-August-University Göttingen, at the Hospital Bremen-East, and at the Hospital of the Johannes-Gutenberg-University Mainz.

About the Department of Clinical Neurophysiology at Göttingen University
The main emphasis of the research at the Department of Clinical Neurophysiology at Göttingen University is focused on the field of epilepsy and Morbus Parkinson as well as on the further development of the methods documented in NEMESYS. Moreover, an English NEMESYS version shall carry this documentation standard also to the Anglo-Saxon countries. For further information, please visit www.neurologie.uni-goettingen.de

About MBM Science Bridge GmbH
The MBM Science Bridge GmbH is the technology transfer organization of the University and operates as a mediator between inventors and industry partners. For further information, please visit www.sciencebridge.de

About MEDNOVO Medical Software Solutions GmbH
The MEDNOVO Medical Software Solutions GmbH is specialized in the de-velopment of medical documentation systems and the connection and integration of medical devices with various hospital information systems (HIS). For further information, please visit www.mednovo.de

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...